Biological Markers in Attention Deficit/Hyperactivity Disorder (ADHD)
Completed
Conditions studied: Attention Deficit and Disruptive Behavior Disorder, Attention Deficit Disorder With Hyperactivity
In brief
The purpose of this study is to evaluate individuals with Attention Deficit/Hyperactivity Disorder (ADHD) to learn more about the genetics of the disease. This study is part of other ongoing studies of individuals with ADHD. The study participants have already undergone neurobiological measurements, particularly magnetic resonance imaging (MRI) of the brain, through other research studies. As a follow-up to these studies, participants will next undergo psychiatric interviews, neuropsychological tests, and another MRI. In addition to the clinical evaluation of the participants, further research will be conducted on the genetics of ADHD. These genetic studies will evaluate people with ADHD as well as their family members and a control group of healthy people.
Key facts
- Study ID
- NCT00001206
- Run by
- National Institute of Mental Health (NIMH)
- People needed
- 347
- Starts
- 1985-06-05
- Expected to finish
- 2017-05-15
- Last updated by the study team
- 2019-12-16
Who can join
Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
Where it is running
- National Institutes of Health Clinical Center, 9000 Rockville Pike — Bethesda, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.